vs

Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and GENESIS ENERGY LP (GEL). Click either name above to swap in a different company.

Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $440.8M, roughly 1.9× GENESIS ENERGY LP). GENESIS ENERGY LP runs the higher net margin — 4.5% vs 0.5%, a 4.0% gap on every dollar of revenue. On growth, GENESIS ENERGY LP posted the faster year-over-year revenue change (10.5% vs 7.5%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs 0.7%).

Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.

Genesis Energy LP is a U.S.-based midstream energy limited partnership that operates critical infrastructure for crude oil, natural gas, refined petroleum products, and specialty industrial materials. Its core assets include pipelines, storage terminals, marine facilities, and rail logistics hubs, serving refineries, industrial clients, and energy distributors across North America.

ACHC vs GEL — Head-to-Head

Bigger by revenue
ACHC
ACHC
1.9× larger
ACHC
$829.0M
$440.8M
GEL
Growing faster (revenue YoY)
GEL
GEL
+3.0% gap
GEL
10.5%
7.5%
ACHC
Higher net margin
GEL
GEL
4.0% more per $
GEL
4.5%
0.5%
ACHC
Faster 2-yr revenue CAGR
ACHC
ACHC
Annualised
ACHC
2.0%
0.7%
GEL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACHC
ACHC
GEL
GEL
Revenue
$829.0M
$440.8M
Net Profit
$4.5M
$19.9M
Gross Margin
Operating Margin
20.4%
Net Margin
0.5%
4.5%
Revenue YoY
7.5%
10.5%
Net Profit YoY
-50.8%
140.2%
EPS (diluted)
$0.05
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACHC
ACHC
GEL
GEL
Q1 26
$829.0M
Q4 25
$821.5M
$440.8M
Q3 25
$851.6M
$414.0M
Q2 25
$869.2M
$377.3M
Q1 25
$770.5M
$398.3M
Q4 24
$774.2M
$398.9M
Q3 24
$815.6M
$397.3M
Q2 24
$796.0M
$430.2M
Net Profit
ACHC
ACHC
GEL
GEL
Q1 26
$4.5M
Q4 25
$-1.2B
$19.9M
Q3 25
$36.2M
$9.2M
Q2 25
$30.1M
$-406.0K
Q1 25
$8.4M
$-469.1M
Q4 24
$32.6M
$-49.4M
Q3 24
$68.1M
$-17.2M
Q2 24
$78.5M
$-8.7M
Operating Margin
ACHC
ACHC
GEL
GEL
Q1 26
Q4 25
-142.4%
20.4%
Q3 25
4.7%
19.0%
Q2 25
5.8%
17.9%
Q1 25
1.7%
5.5%
Q4 24
4.9%
3.4%
Q3 24
12.1%
12.2%
Q2 24
13.4%
11.6%
Net Margin
ACHC
ACHC
GEL
GEL
Q1 26
0.5%
Q4 25
-143.3%
4.5%
Q3 25
4.3%
2.2%
Q2 25
3.5%
-0.1%
Q1 25
1.1%
-117.8%
Q4 24
4.2%
-12.4%
Q3 24
8.4%
-4.3%
Q2 24
9.9%
-2.0%
EPS (diluted)
ACHC
ACHC
GEL
GEL
Q1 26
$0.05
Q4 25
$-12.98
$0.04
Q3 25
$0.40
$-0.05
Q2 25
$0.33
$-0.12
Q1 25
$0.09
$-4.06
Q4 24
$0.36
$-0.58
Q3 24
$0.74
$-0.32
Q2 24
$0.85
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACHC
ACHC
GEL
GEL
Cash + ST InvestmentsLiquidity on hand
$158.5M
$6.4M
Total DebtLower is stronger
$2.5B
$3.0B
Stockholders' EquityBook value
$2.0B
Total Assets
$5.5B
$4.9B
Debt / EquityLower = less leverage
1.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACHC
ACHC
GEL
GEL
Q1 26
$158.5M
Q4 25
$133.2M
$6.4M
Q3 25
$118.7M
$4.9M
Q2 25
$131.4M
$4.5M
Q1 25
$91.2M
$377.4M
Q4 24
$76.3M
$7.4M
Q3 24
$82.1M
$13.0M
Q2 24
$77.2M
$13.7M
Total Debt
ACHC
ACHC
GEL
GEL
Q1 26
$2.5B
Q4 25
$2.5B
$3.0B
Q3 25
$2.3B
$3.1B
Q2 25
$2.3B
$3.1B
Q1 25
$2.2B
$3.4B
Q4 24
$2.0B
$3.7B
Q3 24
$1.9B
$4.0B
Q2 24
$1.8B
$3.9B
Stockholders' Equity
ACHC
ACHC
GEL
GEL
Q1 26
$2.0B
Q4 25
$1.9B
Q3 25
$3.1B
Q2 25
$3.1B
Q1 25
$3.0B
Q4 24
$3.1B
Q3 24
$3.0B
Q2 24
$3.0B
Total Assets
ACHC
ACHC
GEL
GEL
Q1 26
$5.5B
Q4 25
$5.5B
$4.9B
Q3 25
$6.4B
$4.9B
Q2 25
$6.3B
$4.8B
Q1 25
$6.1B
$5.2B
Q4 24
$6.0B
$7.0B
Q3 24
$5.9B
$7.1B
Q2 24
$5.7B
$7.0B
Debt / Equity
ACHC
ACHC
GEL
GEL
Q1 26
1.29×
Q4 25
1.28×
Q3 25
0.74×
Q2 25
0.74×
Q1 25
0.72×
Q4 24
0.64×
Q3 24
0.62×
Q2 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACHC
ACHC
GEL
GEL
Operating Cash FlowLast quarter
$61.5M
$110.8M
Free Cash FlowOCF − Capex
$87.0M
FCF MarginFCF / Revenue
19.7%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
13.78×
5.58×
TTM Free Cash FlowTrailing 4 quarters
$65.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACHC
ACHC
GEL
GEL
Q1 26
$61.5M
Q4 25
$-86.3M
$110.8M
Q3 25
$73.2M
$70.3M
Q2 25
$133.5M
$47.0M
Q1 25
$11.5M
$24.8M
Q4 24
$116.7M
$74.0M
Q3 24
$163.1M
$87.3M
Q2 24
$171.1M
$104.7M
Free Cash Flow
ACHC
ACHC
GEL
GEL
Q1 26
Q4 25
$-179.5M
$87.0M
Q3 25
$-63.0M
$43.3M
Q2 25
$-34.2M
$-7.6M
Q1 25
$-163.2M
$-56.8M
Q4 24
$-86.8M
$-47.1M
Q3 24
$-27.1M
$-32.3M
Q2 24
$16.9M
$-67.5M
FCF Margin
ACHC
ACHC
GEL
GEL
Q1 26
Q4 25
-21.8%
19.7%
Q3 25
-7.4%
10.5%
Q2 25
-3.9%
-2.0%
Q1 25
-21.2%
-14.3%
Q4 24
-11.2%
-11.8%
Q3 24
-3.3%
-8.1%
Q2 24
2.1%
-15.7%
Capex Intensity
ACHC
ACHC
GEL
GEL
Q1 26
Q4 25
11.3%
5.4%
Q3 25
16.0%
6.5%
Q2 25
19.3%
14.5%
Q1 25
22.7%
20.5%
Q4 24
26.3%
30.3%
Q3 24
23.3%
30.1%
Q2 24
19.4%
40.0%
Cash Conversion
ACHC
ACHC
GEL
GEL
Q1 26
13.78×
Q4 25
5.58×
Q3 25
2.02×
7.63×
Q2 25
4.43×
Q1 25
1.37×
Q4 24
3.58×
Q3 24
2.39×
Q2 24
2.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACHC
ACHC

Acute Inpatient Psychiatric Facilities$471.0M57%
Other$140.0M17%
Specialty Treatment Facilities$128.0M15%
Residential Treatment Facilities$90.0M11%

GEL
GEL

Onshore Facilities And Transportation Revenue$204.2M46%
Offshore Pipeline Transportation Revenue$154.3M35%
Marine Transportation Revenue$82.2M19%

Related Comparisons